Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Steroid Pulse Therapy in AE-IPF
NCT04996303Completed
- Sponsor
- Yonsei University
- Start
- Jul 2021
- Primary completion
- Jul 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of methylprednisolone in idiopathic pulmonary fibrosis (IPF) (2 arms), sponsored by Yonsei University. Primary endpoint: Mortality rate at 3 months. Started Jul 2021; status: completed.
02
Drugs
methylprednisolone
03
Conditions
idiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on NCT04996303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04996303.